top of page
Copy of MY MUST HAVE GLP-1 COMPANION! (1).png

on the pen doesn't exist without your

generosity

I'm Dave. On The Pen is my thing. My passion. But so are my 4 kids, and so is my day job. In order to sustain my efforts, I have to cover the costs involved with OTP. The website, the programs that make it pretty, and the tools that help people connect to it. A gift of ANY amount is greatly appreciated!

Untitled design (4).png

Higher Doses of Zepbound and Mounjaro Being Tested

As we continually seek more effective strategies in managing type 2 diabetes and obesity, emerging research into higher doses of tirzepatide presents promising new options, particularly for those who have seen limited results from current dosages. The latest study delves into the potential of 2 investigational higher doses— 20mg and 25mg according to our sources.



The clinical trial, officially referenced as NCT06037252, is rigorously designed to evaluate the safety and efficacy of tirzepatide in doses previously unexplored. This investigation focuses specifically on whether increased doses can provide enhanced benefits that many patients desperately need.


For patients categorized as “slower responders” to the existing maximum dose of 15mg, these investigational doses may offer the breakthrough needed. By intensifying the treatment, there is potential not only to enhance glucose control but also to accelerate weight loss outcomes—key factors in managing type 2 diabetes and associated obesity.


This ongoing study could mark a significant advancement in treatment options, providing new hope and potentially more robust solutions for individuals whose needs surpass the current offerings. Trial NCT06037252 officially commenced on September 21, 2023, with the primary endpoints of the study expected to be reached by December 24, 2024. Preliminary results will soon shed light on the efficacy and safety of the higher doses. The entire study is anticipated to wrap up by September 30, 2025, providing comprehensive data that could potentially reshape current treatment paradigms for those who have had limited success with existing therapies.



WE RELY ON YOUR GENEROSITY FOR THE WORK WE DO, CONSIDER A GIFT THROUGH CASH APP OR VENMO TO SUPPORT OUR CONTINUED AND TIRELESS EFFORTS!


1,025 views0 comments

Recent Posts

See All

Comentarios


bottom of page